Found: 15
Select item for more details and to access through your institution.
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00599-6
- By:
- Publication type:
- Article
Characterization of HOXB13 expression patterns in localized and metastatic castration‐resistant prostate cancer.
- Published in:
- Journal of Pathology, 2024, v. 262, n. 1, p. 105, doi. 10.1002/path.6216
- By:
- Publication type:
- Article
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37874-2
- By:
- Publication type:
- Article
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34665-z
- By:
- Publication type:
- Article
Paracrine Wnt signaling is necessary for prostate epithelial proliferation.
- Published in:
- Prostate, 2022, v. 82, n. 5, p. 517, doi. 10.1002/pros.24298
- By:
- Publication type:
- Article
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first‐line platinum chemotherapy in high grade serous ovarian cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 9, p. 3045, doi. 10.1002/cam4.3831
- By:
- Publication type:
- Article
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Proliferation Tumour Marker Network (PTM-NET) for the identification of tumour region in Ki67 stained breast cancer whole slide images.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49139-4
- By:
- Publication type:
- Article
Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.
- Published in:
- Prostate, 2016, v. 76, n. 9, p. 810, doi. 10.1002/pros.23171
- By:
- Publication type:
- Article
Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: Results from the University of Washington Rapid Autopsy Series.
- Published in:
- Journal of Bone & Mineral Research, 2013, v. 28, n. 2, p. 333, doi. 10.1002/jbmr.1749
- By:
- Publication type:
- Article
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
- Published in:
- Nature, 2010, v. 468, n. 7320, p. 103, doi. 10.1038/nature09495
- By:
- Publication type:
- Article
The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.
- Published in:
- Prostate, 2010, v. 70, n. 4, p. 412, doi. 10.1002/pros.21075
- By:
- Publication type:
- Article
Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells.
- Published in:
- Prostate, 2002, v. 52, n. 1, p. 20, doi. 10.1002/pros.10091
- By:
- Publication type:
- Article